Kestra Advisory Services
BIIB icon

Kestra Advisory Services’s Biogen BIIB Stock Holding History

Kestra Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.46M Buy
6,462
+308
+5% +$65.3K ﹤0.01% 1684
2026
Q2 		$1.33M Buy
6,154
+344
+6% +$65.8K ﹤0.01% 1626
2026
Q1 		$1.07M Buy
5,810
+1,301
+29% +$240K ﹤0.01% 1685
2025
Q4 		$794K Buy
4,509
+2,387
+112% +$390K ﹤0.01% 1823
2025
Q3 		$297K Sell
2,122
-105
-5% -$14.2K ﹤0.01% 2452
2025
Q2 		$280K Buy
2,227
+314
+16% +$39.1K ﹤0.01% 2406
2025
Q1 		$262K Sell
1,913
-236
-11% -$33.7K ﹤0.01% 2269
2024
Q4 		$329K Sell
2,149
-107
-5% -$18K ﹤0.01% 2158
2024
Q3 		$437K Sell
2,256
-662
-23% -$138K ﹤0.01% 1853
2024
Q2 		$676K Buy
2,918
+28
+1% +$6.08K ﹤0.01% 1583
2024
Q1 		$623K Buy
2,890
+119
+4% +$27.9K ﹤0.01% 1520
2023
Q4 		$717K Buy
2,771
+113
+4% +$27.8K 0.01% 1301
2023
Q3 		$683K Sell
2,658
-371
-12% -$99.2K 0.01% 1199
2023
Q2 		$863K Buy
3,029
+750
+33% +$223K 0.01% 1049
2023
Q1 		$634K Sell
2,279
-6,163
-73% -$1.71M 0.01% 1161
2022
Q4 		$2.34M Sell
8,442
-109
-1% -$30.8K 0.02% 686
2022
Q3 		$2.28M Sell
8,551
-491
-5% -$104K 0.02% 621
2022
Q2 		$1.84M Sell
9,042
-410
-4% -$83.8K 0.02% 703
2022
Q1 		$1.99M Buy
9,452
+2,190
+30% +$476K 0.02% 677
2021
Q4 		$1.74M Sell
7,262
-4,888
-40% -$1.26M 0.02% 745
2021
Q3 		$3.44M Sell
12,150
-2,346
-16% -$769K 0.03% 516
2021
Q2 		$5.02M Buy
14,496
+525
+4% +$159K 0.06% 361
2021
Q1 		$3.91M Buy
13,971
+9,462
+210% +$2.55M 0.05% 387
2020
Q4 		$1.1M Buy
4,509
+4,483
+17,242% +$1.16M 0.01% 833
2020
Q3 		$633K Buy
+26
New +$7.25K 0.01% 788

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Kestra Advisory Services's BIIB Position: Q3 2026 in Review

Kestra Advisory Services increased its Biogen (BIIB) stake by 5% in Q3 2026, buying an estimated $65.3K and bringing the position to 6,462 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1684.

Kestra Advisory Services first reported a position in BIIB in Q3 2020 and has held it in 25 quarters since. The position peaked at $5.02M in Q2 2021. 643 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Kestra Advisory Services held 6,462 shares of Biogen worth $1.46M as of Q3 2026.
  • Kestra Advisory Services bought 308 Biogen shares in Q3 2026, an estimated $65.3K.
  • Biogen made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #1684 holding.
  • Kestra Advisory Services first reported a position in Biogen in Q3 2020 and has held it in 25 quarters since.
  • Kestra Advisory Services's Biogen position peaked at $5.02M in Q2 2021.
  • 643 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.